Press "Enter" to skip to content

Pfizer COVID-19 booster shot Rejected by FDA

Pfizer COVID-19 booster shot has been rejected by the influential federal Food and Drug Administration advisory panel.

Moreover, the panel has recommended the substitute plan to administer a booster shot to those 65 and older, as well as to individuals at a higher risk of coronavirus. The booster shot will be given after the six months of the second dose of COVID.

Earlier, the White House pledge to deliver the vaccine booster shot to protect the people from the highly contagious Delta variant.

After several hours of discussion, members of the FDA panel raised concerns that Pfizer has provided little data on the safety of extra doses. The FDA panel also criticizes that the data shown by the Israeli scientist is not suitable for envisaging the U.S. practice.

Pfizer COVID-19 booster shot Rejected by FDA

Now, the booster shot will be available to those people who fall under the “high risk” category. And also the booster shot will be given after the people who get full vaccinated of Pfizer-BioNTech’s vaccine.

The FDA has approved Pfizer’s two-dose vaccine in August and also has authorized a third Pfizer and Moderna dose for certain people with low immunity. But still, a federal scientist has rejected the booster shot for everyone.

The recent studies also show that the effectiveness of the vaccine may start to weakening after six to eight months, a vaccine booster would be allowed for supplementary immune protection against the COVID-19 and different variants.

The US government said that they have a sufficient supply of all three vaccines available in the US, including J&J, Pfizer, and Moderna.